Under Art. 3, par. 3 of Regulation No. 22 if the issue, listed in the register, is not approved for trade on the regulated market within 3 months after its registration, it shall be delisted from the register by initiative of the deputy-chairman in charge of “Investment Activity Supervision” department.
Chaikapharma was supposed to take measures to register the above-mentioned issue on BSE-Sofia between 29 Janaury 2007 and 2 May 2007, the commission said.
Considering the fact that since 29 January 2007 the 5,299,000 share issue of Chaikapharma has not been admitted for trade, it should be delisted from the register.
As a result of its delisting Chaikapharma wil lose its public status and will be removed from the register of public companies and other issuers, kept by the Financial Supervision Commission.
The deputy-chairman of the Financial Supervision Commission has set a 3-working day terms from the publishing of the current announcement, in which all interested parties in the initiated proceedings can submit written objections.